Samsung Electronics Co., Ltd. has received authorization from the United States Food and Drug Administration (FDA) for its Sleep Apnea Feature, a groundbreaking software-only application designed to detect signs of moderate-to-severe obstructive sleep apnea in adults aged 22 and older. The FDA’s approval marks a significant milestone for Samsung, as it becomes the first of its kind to receive De Novo authorization following previous approval by South Korea’s Ministry of Food and Drug Safety (MFDS).
What is the Samsung Sleep Apnea feature?
The Samsung Sleep Apnea Feature is an FDA-authorized software-only application available on the Samsung Health Monitor app, designed to detect signs of moderate-to-severe obstructive sleep apnea in adults aged 22 and older using compatible Samsung Galaxy devices. It utilizes smartwatch built-in sensors to monitor sleep patterns and identify significant breathing disruptions associated with sleep apnea.
Key takeaways
- Samsung’s Sleep Apnea Feature is now FDA authorized, allowing users to detect signs of moderate-to-severe obstructive sleep apnea using compatible Galaxy devices.
- Users over the age of 22, who have not been previously diagnosed with sleep apnea, can monitor their sleep for breathing disruptions over a two-night period using the feature.
- Obstructive sleep apnea is a common and chronic sleep condition that often goes undiagnosed and untreated, leading to disruptions in oxygen supply, lower sleep quality, and daytime fatigue.
- Untreated sleep apnea increases the risk of cardiovascular diseases such as hypertension, coronary artery disease, heart failure, cardiac arrhythmias, and stroke.
- Samsung’s commitment to providing better sleep tools aims to help users improve their sleep health habits, with the feature set to be available on the Galaxy Watch series in the US via the Samsung Health Monitor app in the third quarter.
Overview
In conclusion, Samsung’s Sleep Apnea Feature represents a significant advancement in sleep health technology, empowering users to proactively monitor their sleep and seek medical care to mitigate potential health-related complications associated with untreated sleep apnea.
Related Resources
- Radiology Blog
- Healthcare Business News
- fda.gov/news-events/press-announcements/fda-roundup-february-9-2024
Helpful Resources
The information provided by MRIPETCTSOURCE (“we,” “us,” or “our”) on https://www.medicalimagingsource.com (the “Site”) is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability, or completeness of any information on the Site. UNDER NO CIRCUMSTANCE SHALL WE HAVE ANY LABILITY TO YOU FOR ANY LOSS OR DAMAGE OF ANY KIND INCURRED AS A RESULT OF THE USE OF THE SITE OR RELIANCE ON ANY INFORMATION PROVIDED ON THE SITE. YOUR USE OF THE SITE AND YOUR RELIANCE ON ANY INFORMATION ON THE SITE IS SOLELY AT YOUR OWN RISK.
